Found: 6
Select item for more details and to access through your institution.
1128-P: Empagliflozin and Obstructive Sleep Apnea (OSA): Exploratory Analysis from the EMPA-REG OUTCOME Trial.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-1128-P
- By:
- Publication type:
- Article
Lessons Learned From Major Clinical Outcomes Trials Involving Sodium–Glucose Cotransporter 2 Inhibitors.
- Published in:
- Diabetes Spectrum, 2021, v. 34, n. 3, p. 235, doi. 10.2337/ds20-0070
- By:
- Publication type:
- Article
Role of metformin in the management of type 2 diabetes: recent advances.
- Published in:
- Polish Archives of Internal Medicine, 2023, v. 133, n. 6, p. 1, doi. 10.20452/pamw.16511
- By:
- Publication type:
- Article
Ertugliflozin and incident obstructive sleep apnea: an analysis from the VERTIS CV trial.
- Published in:
- Sleep & Breathing, 2023, v. 27, n. 2, p. 669, doi. 10.1007/s11325-022-02594-2
- By:
- Publication type:
- Article
Response to Comment on Neeland et al. The Impact of Empagliflozin on Obstructive Sleep Apnea and Cardiovascular and Renal Outcomes: An Exploratory Analysis of the EMPA-REG OUTCOME Trial. Diabetes Care 2020;43:3007-3015.
- Published in:
- 2021
- By:
- Publication type:
- letter
The Impact of Empagliflozin on Obstructive Sleep Apnea and Cardiovascular and Renal Outcomes: An Exploratory Analysis of the EMPA-REG OUTCOME Trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article